Detalles de la búsqueda
1.
Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3.
Int J Gynecol Cancer
; 31(7): 949-958, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34103386
2.
Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group.
J Geriatr Oncol
; 12(3): 410-415, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33357975
3.
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety.
Cancer Med
; 10(20): 7162-7173, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34549539
4.
PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis.
J Clin Med
; 9(7)2020 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32635291
5.
Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience.
Transl Lung Cancer Res
; 7(3): 404-415, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30050778
Resultados
1 -
5
de 5
1
Próxima >
>>